Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Global Blood nets $193mm in public offering

Executive Summary

Global Blood Therapeutics Inc. netted $193mm through a public offering of 3.4mm common shares at $59.25. Proceeds will support continued development and future commercialization activities surrounding voxelotor for sickle cell disease, and will also go towards R&D of additional projects including inclacumab for vaso-occlusive crisis.
Deal Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • FOPO

Related Companies